Several state pharmacy boards are moving to restrict pharmacy sales of malarial drugs because patients with auto-immune conditions are having a difficult time getting the drug after President Donald Trump repeatedly touted chloroquine and its less toxic derivative hydroxychloroquine as a likely COVID-19 treatment. Some governors, including New York Gov. Andrew Cuomo (D) and Nevada Gov. Steve Sisolak (D), have gotten much attention for using their executive powers to restrict sales of the anti-malarials. Sisolak on Tuesday (March 24) used...